Current flu virus may mutate and evade vaccine, CDC warns
the ONA take:
Although the flu season has just recently begun, the Centers for Disease Control and Prevention (CDC) issued a health warning about the current flu vaccine.
This vaccine prevents against three to four strains of the virus, but may not affect the H3N2 strain, which has infected most people but has mutated so that the vaccine won’t prevent the virus in half of the cases.
When flu viruses mutate, which happens quite often, they are called “drifts”, and since vaccines are formulated months in advance, they won’t protect well against these drifted viruses, but may provide cross-protection.
Although cross-protection won’t complete prevent the virus, it may help reduce the likelihood of severe outcomes, particularly for those at highest risk, including the elderly and very young children. The CDC still recommends everyone 6 months or older should receive the vaccine, despite the mutated strain.
The Centers for Disease Control and Prevention (CDC) issued a health warning about the current flu vaccine.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|